BIOLASE (NASDAQ:BIOL) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL) in a research report report published on Thursday. The firm issued a sell rating on the medical technology company’s stock.

BIOL has been the subject of a number of other reports. Ascendiant Capital Markets dropped their price target on shares of BIOLASE from $3.50 to $2.00 and set a “buy” rating for the company in a research note on Tuesday, September 3rd. Benchmark reissued a “speculative buy” rating and set a $0.40 price target on shares of BIOLASE in a research note on Wednesday, October 2nd.

BIOLASE Stock Performance

Shares of BIOL stock opened at $0.01 on Thursday. BIOLASE has a 1 year low of $0.02 and a 1 year high of $1.94. The firm’s 50 day moving average is $0.02 and its 200-day moving average is $0.07. The firm has a market capitalization of $167,035.00, a price-to-earnings ratio of 0.00 and a beta of 0.67.

Institutional Investors Weigh In On BIOLASE

An institutional investor recently raised its position in BIOLASE stock. Virtu Financial LLC raised its position in BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 143,537 shares of the medical technology company’s stock after purchasing an additional 131,248 shares during the period. Virtu Financial LLC owned approximately 0.43% of BIOLASE worth $27,000 as of its most recent filing with the SEC. 8.79% of the stock is currently owned by institutional investors.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.